Brief: Sinomab Bioscience Posts FY Loss Attributable Rmb276.3 Mln Vs Loss Of Rmb83.6 Mln
23/03/2020 15:44
March 23 (Reuters) - SinoMab BioScience Ltd 3681.HK :
* FY LOSS ATTRIBUTABLE RMB276.3 MILLION VERSUS LOSS OF
RMB83.6
MILLION
* EXPECT TO FILE SM03 BLA FOR RHEUMATOID ARTHRITIS WITH NMPA
IN
FIRST HALF OF 2021
Source text for Eikon: ID:nHKSFxgmF
Further company coverage: 3681.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sinomab Bioscience
See all newsBrief: Sinomab Bioscience Posts HY Loss Of RMB127.4 Million
Brief: Sinomab Bioscience Says Fang Liang Resigns As Executive Director
Brief: Sinomab Bioscience Announces Major Deal For Disposal Of Suzhou Property And Facility For RMB280 MLN
Brief: SinoMab Bioscience Appoints Fang Liang As Executive Director
Brief: Hainan Haiyao Plans To Unload Stake In Sinomab Bioscience